Literature DB >> 8675258

Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

T Nishikimi1, F Yoshihara, A Morimoto, K Ishikawa, T Ishimitsu, Y Saito, K Kangawa, H Matsuo, T Omae, H Matsuoka.   

Abstract

Previous studies have shown that plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are increased in essential hypertension. However, whether left ventricular geometry affects plasma ANP and BNP levels remains unknown. To investigate the effect of left ventricular geometry on plasma ANP and BNP levels in essential hypertension, we measured plasma ANP and BNP levels in 90 patients with essential hypertension. All patients were hospitalized, and fasting blood samples were obtained in the early morning after 30 minutes of bed rest. Plasma ANP and BNP levels were measured by immunoradiometric assay. Hypertensive patients were classified into four groups according to echocardiographic findings that showed normal geometry, concentric remodeling, eccentric hypertrophy, or concentric hypertrophy. Mean plasma ANP and BNP levels in all essential hypertensive patients were higher than those in age-matched normotensive control subjects. Plasma ANP levels in hypertensive patients with concentric remodeling, eccentric hypertrophy, and concentric hypertrophy were higher than in normotensive control subjects, although there were no differences between normotensive subjects and hypertensive patients with normal geometry. Plasma BNP levels tended to be higher in hypertensive patients with normal geometry, concentric remodeling, and eccentric hypertrophy than in normotensive control subjects; however, the differences were not significant. Plasma BNP levels and BNP/ANP ratio were specifically higher in concentric hypertrophy. There were significant correlations between ANP and left ventricular mass index, relative wall thickness, interventricular septal thickness, posterior wall thickness, and mean arterial pressure. Plasma BNP levels significantly correlated with relative wall thickness, interventricular septal thickness, posterior wall thickness, and left ventricular mass index but not with mean arterial pressure. In addition, plasma BNP levels were well correlated with ANP levels, and the slope for the linear regression model was steeper in concentric hypertrophy than in the other four groups. These results show that plasma ANP and BNP levels are increased in essential hypertensive patients with left ventricular hypertrophy. Furthermore, BNP secretion is augmented to a greater extent in concentric hypertrophy. Thus, measurement of plasma ANP and BNP levels may be useful for the detection of concentric left ventricular hypertrophy in patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675258     DOI: 10.1161/01.hyp.28.1.22

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  49 in total

Review 1.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

2.  Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Xuan Cai; Jungwha Lee; Julia J Scialla; Nisha Bansal; James H Sondheimer; Jing Chen; L Lee Hamm; Ana C Ricardo; Sankar D Navaneethan; Rajat Deo; Mahboob Rahman; Harold I Feldman; Alan S Go; Tamara Isakova; Myles Wolf
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

Review 3.  Natriuretic peptides in cardiovascular diseases: current use and perspectives.

Authors:  Massimo Volpe; Speranza Rubattu; John Burnett
Journal:  Eur Heart J       Date:  2013-11-13       Impact factor: 29.983

4.  Determinants of plasma brain natriuretic peptide levels in untreated hypertensive patients.

Authors:  Akiko Goda; Shinji Nakao; Takeshi Tsujino; Masao Yuba; Misato Otsuka; Mika Matsumoto; Chikako Yoshida; Yoshiro Naito; Masaaki Lee-Kawabata; Mitsumasa Ohyanagi; Tohru Masuyama
Journal:  J Echocardiogr       Date:  2011-04-01

Review 5.  Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.

Authors:  Camilla Calvieri; Speranza Rubattu; Massimo Volpe
Journal:  J Mol Med (Berl)       Date:  2011-08-09       Impact factor: 4.599

6.  Exposure to chronic alcohol accelerates development of wall stress and eccentric remodeling in rats with volume overload.

Authors:  Alan J Mouton; Van K Ninh; Elia C El Hajj; Milad C El Hajj; Nicholas W Gilpin; Jason D Gardner
Journal:  J Mol Cell Cardiol       Date:  2016-04-20       Impact factor: 5.000

Review 7.  [Hypertension and cardiac failure].

Authors:  C M Schannwell; M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

8.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors:  J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  High Plasma Levels of the B-type Natriuretic Peptide in Patients Without Heart Failure: Is There Clinical Significance?

Authors:  Long Hao Yu; Moo Hyun Kim; Jong Seong Park; Kwang Soo Cha; Tae Ho Park; Young Dae Kim
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

10.  Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Mariana Lazo; Yuan Chen; John W McEvoy; Chiadi Ndumele; Suma Konety; Christie M Ballantyne; A Richey Sharrett; Elizabeth Selvin
Journal:  Clin Chem       Date:  2016-07-20       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.